Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma

Figure 8

Immune therapy and immune escape between two groups. (a) The box plot demonstrated the comparison of the expressions of eight immune checkpoints molecules. (b) The association of risk score and the expressions of eight immune checkpoint molecules. (c) Comparison of TIDE score between two groups. Waterfall of the first twenty mutated genes in the (d) high- and (e) low-risk groups. (f) Comparison of tumor mutation burden between two groups. (g) The correlation between risk score and tumor mutation burden.

(a)

(b)

(c)

(d)

(e)

(f)

(g)